www.prnewswire.com
Open in
urlscan Pro
2606:4700:4400::ac40:9a3d
Public Scan
URL:
https://www.prnewswire.com/news-releases/quest-diagnostics-adds-diabetic-retinopathy-screening-through-its-patient-service-...
Submission: On November 03 via api from US — Scanned from DE
Submission: On November 03 via api from US — Scanned from DE
Form analysis 1 forms found in the DOM
<form class="search-bar">
<div class="input-group">
<input type="hidden" id="sitesearchurl" name="searchlink" value="/search/all/">
<input type="hidden" id="prodsearchurl" name="prodsearchlink" value="/search/products/">
<input type="hidden" id="resourcesearchurl" name="resourcesearchlink" value="/search/resources/">
<input type="hidden" id="orgsearchurl" name="orgsearchlink" value="/search/organization/">
<input type="hidden" id="allnewssearchurl" name="allnewssearchlink" value="/search/news/">
<input type="hidden" id="enableQuickSearch" name="enableQuickSearch" value="true">
<input type="hidden" id="newsVanityPathURL" name="newsVanityPathURL" value="/news/">
<label class="search-label" id="Search">Search</label>
<span class="sr-only" id="autopoplabel">When typing in this field, a list of search results will appear and be automatically updated as you type.</span>
<input type="text" id="sitesearchbox" name="Search" aria-describedby="autopoplabel" autocomplete="off" class="form-control form-search" placeholder="Search News Releases, Organizations, Resources, and Products"
aria-label="Search News Releases, Organizations, Resources, and Products">
</div>
<div class="qs-error">
</div>
</form>Text Content
Close menu
NewsProductsContact
* Send a Release
* Sign Up
* Log In
* Resources
* Blog
* Journalists
* RSS
* GDPR
*
* 3 News in Focus
* 5 Business & Money
* 5 Science & Tech
* 5 Lifestyle & Health
* 0 Policy & Public Interest
* 1 People & Culture
* Send a Release
* Sign Up
* Log In
* Resources
* Blog
* Journalists
* RSS
* GDPR
*
* Overview
* Distribution by PR Newswire
* Cision Communications Cloud®
* Cision IR
* All Products
* Send a Release
* Sign Up
* Log In
* Resources
* Blog
* Journalists
* RSS
* GDPR
*
* General Inquiries
* Request a Demo
* Editorial Bureaus
* Partnerships
* Media Inquiries
* Worldwide Offices
* Send a Release
* Sign Up
* Log In
* Resources
* Blog
* Journalists
* RSS
* GDPR
*
Close submenu (News in Focus)News in Focus
* Browse All News
* Multimedia Gallery
* Trending Topics
Close submenu (Business & Money)Business & Money
* Auto & Transportation
* Business Technology
* Entertainment & Media
* Financial Services & Investing
* General Business
Close submenu (Science & Tech)Science & Tech
* Consumer Technology
* Energy & Natural Resources
* Environment
* Heavy Industry & Manufacturing
* Telecommunications
Close submenu (Lifestyle & Health)Lifestyle & Health
* Consumer Products & Retail
* Entertainment & Media
* Health
* Sports
* Travel
Close submenu (Policy & Public Interest)Policy & Public Interest
Close submenu (People & Culture)People & Culture
* People & Culture
* Resources
* Blog
* Journalists
* Log In
* Sign Up
* Data Privacy
* Send a Release
* News
* Products
* Contact
Search
Search When typing in this field, a list of search results will appear and be
automatically updated as you type.
Searching for your content...
No results found. Please change your search terms and try again.
* News in Focus
* * BROWSE NEWS RELEASES
* All News Releases
* All Public Company
* English-only
* NEWS RELEASES OVERVIEW
* MULTIMEDIA GALLERY
* All Multimedia
* All Photos
* All Videos
* MULTIMEDIA GALLERY OVERVIEW
* TRENDING TOPICS
* All Trending Topics
* Business & Money
* * AUTO & TRANSPORTATION
* All Automotive & Transportation
* Aerospace, Defense
* Air Freight
* Airlines & Aviation
* Automotive
* Maritime & Shipbuilding
* Railroads and Intermodal Transportation
* Supply Chain/Logistics
* Transportation, Trucking & Railroad
* Travel
* Trucking and Road Transportation
* AUTO & TRANSPORTATION OVERVIEW
* VIEW ALL AUTO & TRANSPORTATION
* BUSINESS TECHNOLOGY
* All Business Technology
* Blockchain
* Broadcast Tech
* Computer & Electronics
* Computer Hardware
* Computer Software
* Data Analytics
* Electronic Commerce
* Electronic Components
* Electronic Design Automation
* Financial Technology
* High Tech Security
* Internet Technology
* Nanotechnology
* Networks
* Peripherals
* Semiconductors
* BUSINESS TECHNOLOGY OVERVIEW
* VIEW ALL BUSINESS TECHNOLOGY
* ENTERTAINMENT & MEDIA
* All Entertainment & Media
* Advertising
* Art
* Books
* Entertainment
* Film and Motion Picture
* Magazines
* Music
* Publishing & Information Services
* Radio & Podcast
* Television
* ENTERTAINMENT & MEDIA OVERVIEW
* VIEW ALL ENTERTAINMENT & MEDIA
* FINANCIAL SERVICES & INVESTING
* All Financial Services & Investing
* Accounting News & Issues
* Acquisitions, Mergers and Takeovers
* Banking & Financial Services
* Bankruptcy
* Bond & Stock Ratings
* Conference Call Announcements
* Contracts
* Cryptocurrency
* Dividends
* Earnings
* Earnings Forecasts & Projections
* Financing Agreements
* Insurance
* Investments Opinions
* Joint Ventures
* Mutual Funds
* Private Placement
* Real Estate
* Restructuring & Recapitalization
* Sales Reports
* Shareholder Activism
* Shareholder Meetings
* Stock Offering
* Stock Split
* Venture Capital
* FINANCIAL SERVICES & INVESTING OVERVIEW
* VIEW ALL FINANCIAL SERVICES & INVESTING
* GENERAL BUSINESS
* All General Business
* Awards
* Commercial Real Estate
* Corporate Expansion
* Earnings
* Environmental, Social and Governance (ESG)
* Human Resource & Workforce Management
* Licensing
* New Products & Services
* Obituaries
* Outsourcing Businesses
* Overseas Real Estate (non-US)
* Personnel Announcements
* Real Estate Transactions
* Residential Real Estate
* Small Business Services
* Socially Responsible Investing
* Surveys, Polls and Research
* Trade Show News
* GENERAL BUSINESS OVERVIEW
* VIEW ALL GENERAL BUSINESS
* Science & Tech
* * CONSUMER TECHNOLOGY
* All Consumer Technology
* Artificial Intelligence
* Blockchain
* Cloud Computing/Internet of Things
* Computer Electronics
* Computer Hardware
* Computer Software
* Consumer Electronics
* Cryptocurrency
* Data Analytics
* Electronic Commerce
* Electronic Gaming
* Financial Technology
* Mobile Entertainment
* Multimedia & Internet
* Peripherals
* Social Media
* STEM (Science, Tech, Engineering, Math)
* Supply Chain/Logistics
* Wireless Communications
* CONSUMER TECHNOLOGY OVERVIEW
* VIEW ALL CONSUMER TECHNOLOGY
* ENERGY & NATURAL RESOURCES
* All Energy
* Alternative Energies
* Chemical
* Electrical Utilities
* Gas
* General Manufacturing
* Mining
* Mining & Metals
* Oil & Energy
* Oil and Gas Discoveries
* Utilities
* Water Utilities
* ENERGY & NATURAL RESOURCES OVERVIEW
* VIEW ALL ENERGY & NATURAL RESOURCES
* ENVIRONMENT
* All Environment
* Conservation & Recycling
* Environmental Issues
* Environmental Policy
* Environmental Products & Services
* Green Technology
* Natural Disasters
* ENVIRONMENT OVERVIEW
* VIEW ALL ENVIRONMENT
* HEAVY INDUSTRY & MANUFACTURING
* All Heavy Industry & Manufacturing
* Aerospace & Defense
* Agriculture
* Chemical
* Construction & Building
* General Manufacturing
* HVAC (Heating, Ventilation and Air-Conditioning)
* Machinery
* Machine Tools, Metalworking and Metallurgy
* Mining
* Mining & Metals
* Paper, Forest Products & Containers
* Precious Metals
* Textiles
* Tobacco
* HEAVY INDUSTRY & MANUFACTURING OVERVIEW
* VIEW ALL HEAVY INDUSTRY & MANUFACTURING
* TELECOMMUNICATIONS
* All Telecommunications
* Carriers and Services
* Mobile Entertainment
* Networks
* Peripherals
* Telecommunications Equipment
* Telecommunications Industry
* VoIP (Voice over Internet Protocol)
* Wireless Communications
* TELECOMMUNICATIONS OVERVIEW
* VIEW ALL TELECOMMUNICATIONS
* Lifestyle & Health
* * CONSUMER PRODUCTS & RETAIL
* All Consumer Products & Retail
* Animals & Pets
* Beers, Wines and Spirits
* Beverages
* Bridal Services
* Cannabis
* Cosmetics and Personal Care
* Fashion
* Food & Beverages
* Furniture and Furnishings
* Home Improvement
* Household, Consumer & Cosmetics
* Household Products
* Jewelry
* Non-Alcoholic Beverages
* Office Products
* Organic Food
* Product Recalls
* Restaurants
* Retail
* Supermarkets
* Toys
* CONSUMER PRODUCTS & RETAIL OVERVIEW
* VIEW ALL CONSUMER PRODUCTS & RETAIL
* ENTERTAINMENT & MEDIA
* All Entertainment & Media
* Advertising
* Art
* Books
* Entertainment
* Film and Motion Picture
* Magazines
* Music
* Publishing & Information Services
* Radio & Podcast
* Television
* ENTERTAINMENT & MEDIA OVERVIEW
* VIEW ALL ENTERTAINMENT & MEDIA
* HEALTH
* All Health
* Biometrics
* Biotechnology
* Clinical Trials & Medical Discoveries
* Dentistry
* FDA Approval
* Fitness/Wellness
* Health Care & Hospitals
* Health Insurance
* Infection Control
* International Medical Approval
* Medical Equipment
* Medical Pharmaceuticals
* Mental Health
* Pharmaceuticals
* Supplementary Medicine
* HEALTH OVERVIEW
* VIEW ALL HEALTH
* SPORTS
* All Sports
* General Sports
* Outdoors, Camping & Hiking
* Sporting Events
* Sports Equipment & Accessories
* SPORTS OVERVIEW
* VIEW ALL SPORTS
* TRAVEL
* All Travel
* Amusement Parks and Tourist Attractions
* Gambling & Casinos
* Hotels and Resorts
* Leisure & Tourism
* Outdoors, Camping & Hiking
* Passenger Aviation
* Travel Industry
* TRAVEL OVERVIEW
* VIEW ALL TRAVEL
* Policy & Public Interest
* * POLICY & PUBLIC INTEREST
* All Policy & Public Interest
* Advocacy Group Opinion
* Animal Welfare
* Congressional & Presidential Campaigns
* Corporate Social Responsibility
* Domestic Policy
* Economic News, Trends, Analysis
* Education
* Environmental
* European Government
* FDA Approval
* Federal and State Legislation
* Federal Executive Branch & Agency
* Foreign Policy & International Affairs
* Homeland Security
* Labor & Union
* Legal Issues
* Natural Disasters
* Not For Profit
* Patent Law
* Public Safety
* Trade Policy
* U.S. State Policy
* POLICY & PUBLIC INTEREST OVERVIEW
* VIEW ALL POLICY & PUBLIC INTEREST
* People & Culture
* * PEOPLE & CULTURE
* All People & Culture
* Aboriginal, First Nations & Native American
* African American
* Asian American
* Children
* Diversity, Equity & Inclusion
* Hispanic
* Lesbian, Gay & Bisexual
* Men's Interest
* People with Disabilities
* Religion
* Senior Citizens
* Veterans
* Women
* PEOPLE & CULTURE OVERVIEW
* VIEW ALL PEOPLE & CULTURE
* In-Language News
* español
* português
* Česko
* Danmark
* Deutschland
* España
* France
* Italia
* Nederland
* Norge
* Polska
* Portugal
* Россия
* Slovensko
* Suomi
* Sverige
* Overview
* Distribution by PR Newswire
* Cision Communications Cloud®
* Cision IR
* Sponsored Placement
* All Products
* General Inquiries
* Request a Demo
* Editorial Bureaus
* Partnerships
* Media Inquiries
* Worldwide Offices
*
*
* Send a Release
*
* * ALL CONTACT INFO
* Contact Us
888-776-0942
from 8 AM - 10 PM ET
*
* *
QUEST DIAGNOSTICS ADDS DIABETIC RETINOPATHY SCREENING THROUGH ITS PATIENT
SERVICE CENTERS IN COLLABORATION WITH IRIS
--------------------------------------------------------------------------------
News provided by
Quest Diagnostics
Apr 04, 2022, 08:55 ET
SHARE THIS ARTICLE
Share this article
--------------------------------------------------------------------------------
New Capability Enables Individuals Identified as High-Risk by Participating
Health Plans to Access Screening through a Quest Diagnostics Site
Builds on Quest's Extended Care Services to Improve Care Quality and Outcomes in
Diabetes and Other Chronic Diseases
SECAUCUS, N.J., April 4, 2022 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the
world's leading provider of diagnostic information services, today announced a
collaboration with IRIS (Intelligent Retinal Imaging Systems) to deliver
diabetic retinal imaging services through designated Quest Diagnostics patient
service centers across the United States to aid in screening patients for
retinal assessment by a healthcare provider. The collaboration aims to increase
convenience and improve screening rates for diabetic retinopathy, the leading
cause of blindness in the United Statesi, for members of population health
management programs sponsored by health plans.
According to the Centers for Disease Control and Prevention, nearly one-third of
patients with diabetes over 40 years old have diabetic retinopathy.ii Screening
to aid early detection and treatment may help prevent the disease from
progressing to blindness.iii While an annual diabetic retinal screening is
medically recommended for patients with diabetes, barriers to care can limit
access to this service.
In 2018, Quest Diagnostics, through its Quest HealthConnect (QHC) business,
began to provide diabetic retinal imaging for use in screening using the IRIS
platform. This platform involves the use of a portable, handheld camera that
captures a patient's retinal images as part of its risk evaluation and care
services for participating health plan members. The new collaboration with IRIS
extends the use of the IRIS platform at Quest's patient service centers.
New service builds on Quest's vision to aid in closing gaps in care for patients
with diabetes
The new service expands on the Quest Diagnostics Extended Care portfolio of
services designed to facilitate access to care beyond traditional healthcare
settings. These services feature home-based risk assessment and monitoring tools
through Quest HealthConnect and coaching for chronic conditions through Pack
Health, which Quest Diagnostics acquired in January 2022. It also includes
services provided by Quest Healthcare Analytics, which utilizes the company's
database of 60 billion laboratory test results to help identify and engage
at-risk members for health plans to close screening gaps and improve care
quality and outcomes.
With training developed by IRIS, designated personnel at Quest patient service
centers will transmit a patient's retinal image to a credentialed, licensed
ophthalmologist to interpret the images. The IRIS Program returns a diagnostic
and patient report to Quest HealthConnect. The results are also transmitted to
the health plan as well as the patient's primary care physician or eye
specialist for follow-up diagnosis and care.
"Limited access to important screenings has allowed the undetected,
sight-threatening progression of diabetic retinopathy to grow," said Christopher
Grant, Vice President & General Manager, Quest HealthConnect. "Through this
collaboration with IRIS, we can now provide a new opportunity to help prevent
sight loss. Leveraging our network of patient service centers will increase
access to screenings for many, ultimately leading to better health outcomes."
"IRIS is thrilled to be joined by Quest Diagnostics, the nation's leading
provider of diagnostic information services, to help mitigate preventable
blindness," said Steve Martin, IRIS CEO. "Through this expanded care network, it
will make it much easier to reach the estimated 60% of people with diabetes that
are currently skipping their annual diabetic retinopathy check.iv"
Diabetic retinopathy is caused by damage to the blood vessels in the retina and
can lead to vision loss or blindness in diabetics. Early detection and treatment
of diabetic retinopathy is crucial to slowing disease progression and preventing
patients from losing their eyesight.
About Quest HealthConnect
Quest HealthConnect's mission is to increase satisfaction among health plan
members by helping them take full advantage of their benefits and enhance the
quality of their care. Quest HealthConnect continues to innovate with real-time
solutions in Patient Service Centers and partners for health risk assessments
and quality member services. For more information, visit QuestHealthConnect.com.
About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes.
Derived from the world's largest database of clinical lab results, our
diagnostic insights reveal new avenues to identify and treat disease, inspire
healthy behaviors, and improve healthcare management. Quest annually serves one
in three adult Americans and half the physicians and hospitals in the United
States, and our 50,000 employees understand that, in the right hands and with
the right context, our diagnostic insights can inspire actions that transform
lives. www.QuestDiagnostics.com.
About IRIS
Intelligent Retinal Imaging Systems' (IRIS) mission is to end preventable
blindness. Their end–to–end comprehensive diagnostic solution enables the
provision of retinal imaging services in a variety of settings to persons at
risk for developing sight-threatening diseases. The IRIS Program is an FDA Class
II cleared cloud-based platform which offers clients the unique ability to
customize their program from hardware to workflow, ultimately improving quality,
increasing access, and reducing costs, but most importantly helping to end
vision loss due to diabetic retinopathy. For more information,
visit www.retinalscreenings.com.
i Common Eye Disorders and Diseases | CDC
ii Diabetic Retinopathy (cdc.gov)
iii People with Diabetes Can Prevent Vision Loss (nih.gov)
iv Sixty Percent of Americans with Diabetes Skip Annual Sight-Saving Exams -
American Academy of Ophthalmology (aao.org)
SOURCE Quest Diagnostics
×
MODAL TITLE
ALSO FROM THIS SOURCE
QUEST DIAGNOSTICS COMPLETES LEADERSHIP SUCCESSION AS JIM DAVIS...
--------------------------------------------------------------------------------
BREAD OF LIFE, INC. TEAMS UP WITH THE QUEST DIAGNOSTICS...
EXPLORE
More news releases in similar topics
* Health Care & Hospitals
* Medical Pharmaceuticals
* Medical Equipment
* New Products & Services
* Contracts
CONTACT CISION
* Cision Distribution 888-776-0942
from 8 AM - 9 PM ET
* Chat with an Expert
Contact Us
* General Inquiries
* Request a Demo
* Editorial Bureaus
* Partnerships
* Media Inquiries
* Worldwide Offices
PRODUCTS
* Cision Communication Cloud®
* For Marketers
* For Public Relations
* For IR & Compliance
* For Agency
* For Small Business
* All Products
ABOUT
* About PR Newswire
* About Cision
* Become a Publishing Partner
* Become a Channel Partner
* Careers
* COVID-19 Resources
* Accessibility Statement
Global Sites
* Asia
* Brazil
* Canada
* Czech
* Denmark
* Finland
* France
* Germany
* India
* Israel
* Italy
* Mexico
* Middle East
* Netherlands
* Norway
* Poland
* Portugal
* Russia
* Slovakia
* Spain
* Sweden
* United Kingdom
MY SERVICES
* All New Releases
* Online Member Center
* ProfNet
CONTACT CISION
PRODUCTS
ABOUT
My Services
* All News Releases
* Online Member Center
* ProfNet
Cision Distribution Helpline
888-776-0942
* Terms of Use
* Privacy Policy
* Information Security Policy
* Site Map
* RSS
* Cookie Settings
Copyright © 2022 Cision US Inc.
PRIVACY PREFERENCE CENTER
When you visit any website, it may store or retrieve information on your
browser, mostly in the form of cookies. This information might be about you,
your preferences or your device and is mostly used to make the site work as you
expect it to. The information does not usually directly identify you, but it can
give you a more personalized web experience. Because we respect your right to
privacy, you can choose not to allow some types of cookies. Click on the
different category headings to find out more and change our default settings.
However, blocking some types of cookies may impact your experience of the site
and the services we are able to offer. More information
Allow All
MANAGE CONSENT PREFERENCES
STRICTLY NECESSARY
Always Active
These technologies are needed to enable our websiteto run and keep it secure.
PERFORMANCE ANALYTICS
Performance Analytics
These technologies tell us how you use our sites and apps, and provide
information to help us improve the website and browser experience.
FUNCTIONAL
Functional
These technologies allow us to provide enhanced functionality and personalise
content for you. For example they're used to recognise you when you return to
our website. If you do not allow these technologies then some or all these
services may not function properly.
MARKETING
Marketing
These services helps us decide which products, services and content may be
relevant for you. We use this data to customise the content you see on our
websites and social media. These technologies are set by us or by our
carefully-selected third parties. They help us understand the performance of our
marketing activities and improve the relevance of the content that you see.
BACK BUTTON PERFORMANCE COOKIES
Vendor Search Search Icon
Filter Icon
Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label
Reject All Confirm My Choices
By clicking “Accept All Cookies”, you agree to the storing of cookies on your
device to enhance site navigation, analyze site usage, and assist in our
marketing efforts.
Reject All Accept All Cookies
Cookies Settings